Pharmaceutical discount agreements from 01.12.2024 for various active ingredients as part of an open-house procedure - 604473

World Biggest Tenders Source

This tender with title Pharmaceutical discount agreements from 01.12.2024 for various active ingredients as part of an open-house procedure - 604473 has been published on Bidding Source portal dated 15 Oct 2024 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Pharmaceutical discount agreements from 01.12.2024 for various active ingredients as part of an open-house procedure - 604473

Tender Type :

Invitation for Bids

Country :

Germany

Publish Date :

15 Oct 2024

Closing Date :

1 Oct 2026

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient vildagliptin (A10BH02) within the framework of a so-called open-house model. - 613970 Germany Pharmaceutical products – Generikaausschreibung - 615315 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient omalizumab (ATC code: R03DX05). - 603710 Germany Pharmaceutical products – 32nd generics tender (antibiotics) - 605746 Germany 32nd Generics Tender (Sustainability) - 612687 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredients brinzolamide and brimonidine (S01EC24) within the framework of a so-called open-house model. - 614283 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code (SGB V) by means of an open-house model for the active ingredient dabigatran etexilate (ATC code according to WHO: B01AE07) - 614350 Germany Pharmaceutical products – Drug tender 01_2024 - 611393 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient paliperidone (N05AX13) and the trade name Trevicta® within the framework of a so-called open-house model. - 613849 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient iron(III) sodium gluconate complex (B03AC07) within the framework of a so-called open-house model. - 615563 Germany

Pharmaceutical discount agreements from 01.12.2024 for various active ingredients as part of an open-house procedure - 604473

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com